Azor FDA Approval History
FDA Approved: Yes (First approved September 26, 2007)
Brand name: Azor
Generic name: amlodipine and olmesartan
Dosage form: Tablets
Previous Name: amlodipine and olmesartan
Company: Daiichi Sankyo, Inc.
Treatment for: High Blood Pressure
Azor is a fixed-dose combination of two antihypertensives, the calcium channel blocker amlodipine besylate and the angiotensin receptor blocker olmesartan medoxomil. Azor is indicated for the treatment of hypertension.
Development timeline for Azor
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.